Introduction
Cortical thymic epithelium (TE) appears to be unique in its capacity to support positive selection, although the underlying mechanism(s) remain(s) poorly understood. Approaches to define the epithelial contributions to this process in vitro have met with some success, the most notable being the reaggregate fetal thymus organ cultures established by Jenkinson et al. (1) , which has identified permissive conditions for short-term thymocyte development in vitro and has demonstrated the capacity of cortical epithelium isolated from enzymatically dissociated fetal thymi to support positive selection in vitro (2) . Short-term primary cultures of thymic stromal cells has also been shown to support thymocyte development in vitro (3) . However, neither of these approaches lend themselves to Correspondence to: A. Farr Transmitting editor: A. Singer Received 23 February 1998 , accepted 25 May 1998 biochemical analyses of cortical TE, due to issues of purity and cell yields. Establishment of cortical TE cell lines from normal mice has proven to be difficult. Several groups have circumvented this problem by generating thymic epithelial cell lines from SV40-T transgenic mice (4) (5) (6) . One SV40-transformed stromal cell line (4) able to support positive selection following intrathymic injection (7) was unable to support this process in vitro (Farr et al., unpublished observations) . Furthermore, the demonstration that intrathymically injected fibroblasts could mediate positive selection (8) has led to the notion that contributions of resident TE and peptide-MHC ligands expressed by injected cells may act in trans to mediate positive selection, thus making it difficult to interpret the functional integrity of intra-thymically injected TE cell lines. Tanaka et al. have recently demonstrated that a conditionally immortalized cortical TE cell line can support positive selection of class I-restricted TCR transgenic thymocytes when incorporated into reaggregation cultures (RC) of normal fetal thymus (9) .
In this study, we have propagated TE from a line of transgenic mice which exhibits thymic hyperplasia as a consequence of E6 and E6 oncogenes from the human papilloma virus 16 expressed as transgenes under control of the keratin 14 promoter (10) . Similar to SV40-T, the combination of these two oncogenes disrupts the regulatory activity of p53 and RB (11) (12) (13) and can lead to cellular transformation (14) . We report here that stromal cell lines propagated from k14E6/E7 thymus retain characteristics of cortical epithelium and supported the in vitro positive selection of cytochrome c-specific αβ TCR AND transgenic CD4 ϩ CD8 ϩ thymocytes in the absence of exogenous peptide. Positive selection by variants of this cell line was dependent on exogenous cognate peptide and could support positive selection in the presence of low but not high concentrations of peptide. In contrast to their ability to support positive selection of AND thymocytes, the ANV thymic epithelial cells did not support peptidespecific activation of purified AND T cells or thymocytes in vitro.
Methods

Mice and cells
The production of k14E6/E7 transgenic mice has been described elsewhere (10) . The AND line of TCR transgenic mice expresses a TCR that recognizes pigeon cytochrome c associated with I-E k and is also positively selected by I-A b MHC molecules (15, 16) . AND mice with a H-2 b background were generously provided by Dr Stephen Hedrick. The TEC epithelial cell line (17) was obtained from Dr A. Kruisbeek. Other epithelial cell lines were produced in this laboratory (18, 19) . Reagents ATCC (Rockville, MD) was the source of the hybridomas producing the following mAb: anti-CD4 (clone GK 1.5), anti-CD45 (clone RA3-3A1/6.1), anti-B7-2 (clone GL-1), anti-mouse CD11c (clone N418), anti-macrophage (clone F4/80), anticlass II MHC antibodies (clones M5/114, 10.3.6, 14.4.4S and Y3P) and anti-Fc receptor (clone 24G2). The following mAb were also used: anti-B7-1 mAb, clone 1610A1 (20) , 6C3 (21), NLDC-145 (22), F23.1 (23), anti-ICAM 1, clone YN-1 (24), anti-CD3, clone 500A2 (25) and anti-VCAM-1, clone M/K-2 (26). G8.8 and 10.1.1 mAb were produced in this laboratory (19, 27) . Anti-CD40 mAb were purchased from Serotec (Oxford, UK). mAb used in tissue culture were purified from serum-free hybridoma culture supernatant by Protein G-affinity chromatography, dialysed extensively against RPMI 1640 culture medium and then sterilized by membrane filtration prior to use. Endotoxin contamination was undetectable by limulus lysate assay (Sigma, St Louis, MO). Phycoerythrinconjugated anti-CD8 mAb were obtained from Caltag (San Francisco, CA). Cy5-conjugated streptavidin was from Southern Biotechnology (Birmingham, AL), and fluorochromeconjugated anti-CD69, anti-CD25 and anti-BrdU mAb were purchased from PharMingen (La Jolla, CA). IFN-γ, IL-1 and tumor necrosis factor (TNF)-α were generously provided by Immunex (Seattle, WA). Moth cytochrome c (MCC) peptide (92-107) was provided by Dr Howard Grey (La Jolla Institute for Allergy and Immunology, San Diego, CA). Concanavalin A and BrdU were purchased from Sigma.
Flow cytometry
Procedures for flow cytometric analyses of thymocytes and thymic stromal cell lines have been previously described (19, 27) . A viability marker, 7-amino-actinomycin D (7AAD; 28), was used in all single-and two-color analyses of thymocytes or stromal cells except in the BrdU assays. Viable thymocytes are shown after gating on forward and side scatter and 7AAD staining or, in the case of anti-BrdU labeling, forward and side scatter and CD4 expression. The total number of viable thymocytes so identified was used to calculate percentages of thymocyte subsets recovered from RC. Processing of samples for BrdU labeling followed the protocol of (29) , with a BrdU concentration of 25 µg/ml. Analyses were performed on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA) and Reproman (TrueFacts Software, Seattle, WA) or CellQuest (Becton Dickinson, Palo Alto, CA) software.
Obtaining cell lines
Pieces of thymus tissue were collected aseptically, minced with scissors and the resulting preparation was washed several times in Ca 2ϩ ,Mg 2ϩ -free HBSS prior to enzymatic dissociation at 37°C with a mixture of dispase I (0.8 U/ml, collagenase (0.1 U/ml) and DNase 150 U/ml (Boehringer Mannheim) dissolved in Ca 2ϩ ,Mg 2ϩ -free HBSS. Dissociation was facilitated by low speed stirring of the reaction mixture with a magnetic stir bar. Dissociated cells were washed with RPMI 1640 supplemented with 10% FBS, penicillin/ streptomycin, L-glutamine and 5ϫ10 -5 M β 2 -mercaptoethanol (complete medium), and then plated in complete medium at a density of 10 6 cells/ml in 10 cm dishes and passaged by treatment with 0.5% EDTA in Ca 2ϩ ,Mg 2ϩ -free HBSS.
Cytokine induction assays ANV 41.2 or 100.4 stromal cells were plated at 25% confluence in the presence of TNF-α, IFN-γ, IL-1 or combinations of cytokines. After 4 days in culture, stromal cells were recovered by treatment with 0.5 mM EDTA in Ca 2ϩ ,Mg 2ϩ -free HBSS. After washing twice, suspensions of cells were processed for flow cytometric analysis. Pilot experiments determined optimal concentrations of TNF-α (10 ng/ml), IFN-γ (100 U/ml) and IL-1 (10 ng/ml).
Thymocyte fractionation
Freshly isolated thymocytes from 6-to 12-day-old AND trangenic mice were suspended at 5ϫ10 7 /ml in HBSS (Gibco) containing 1% FBS and biotinylated anti-CD3 (500A2; 10 µg/ ml) for 20 min on ice. Cells coated with biotinylated mAb were removed by four sequential treatments with streptavidinBioMag beads (PerSeptive Diagnostics, Cambridge MA), according to protocols provided by the manufacturer. To generate purified CD4 SP thymocytes, AND thymocytes were first incubated with a cocktail of biotinylated mAb directed against CD8, B220 and macrophages/dendritic cells (N418), and then treated as above with magnetic beads derivitized with streptavidin. After washing and counting, the cells were resuspended in complete medium. Efficiency of the depletion was monitored with flow cytometry. Purity of CD4 SP thymocytes was Ͼ95%.
RC RC were done as described by Jenkinson et al. (1) with some modifications. Adherent stromal cell cultures were washed with Ca 2ϩ ,Mg 2ϩ -free HBSS and then briefly incubated at 37°C in Ca 2ϩ ,Mg 2ϩ -free HBSS containing 0.5 mM EDTA to recover them. After washing in HBSS and counting, the cells were resuspended in complete medium. To form RC, stromal cells and thymocytes were mixed at a 1:4 ratio in a 1 ml volume in a microfuge tube and then centrifuged (4 min at 200 g). Most of the resulting supernatant was removed and the resulting cell slurry was deposited as small drops on Millipore (HA; Bedford, MA) filters using a fine glass pipette (tip diameter 200 µm). The filters rested on pieces of 7 mm Gelfoam sponges (Upjohn, Kalamazoo, MI) within individual wells of six-chamber tissue culture plates containing 2.5 ml of complete medium. Antibodies (30 µg/ml final concentration) were added to the medium in the well prior to placing the filters on the sponges. Thymocytes were recovered from the RC by treatment with 0.5 mM EDTA and gentle titration. After washing, thymocytes were counted and processed for flow cytometry or proliferation assays.
Proliferation assays
To remove residual stromal cells, thymocytes recovered from RC were suspended in medium (2ϫ10 5 /ml, typically 30 ml) and plated in 15 cm plates. After culturing at 37°C for 90 min to allow adherence of residual stromal cells, the recovered non-adherent cells were then sorted on the basis of forward and side scatter to recover cells displaying a typical lymphocyte gate. For antigen presentation assays, B10.BR or C57Bl/ 6 splenocytes that were treated with Gey's solution to lyse erythrocytes and then treated with mitomycin C. In some experiments, the spleen cells were also depleted of T cells by antibody and complement-mediated lysis of Thy-1 ϩ cells. ANV cells were cultured with IFN-γ as described above and also treated with mitomycin C. Proliferation assays were performed in triplicate, using 96-well flat-bottom tissue culture plates, 5ϫ10 5 stimulator cells and 5-10ϫ10 3 responder cells. MCC peptide was added at the initiation of the cultures. Cultures were pulsed with [ 3 H]thymidine after 84-86 h of culture and harvested at 96 h.
Results
Thymic stromal cell lines derived from k14E6E7 mice resemble cortical epithelium
We established a number of thymic stromal cell lines from k14E6E7 hyperplastic thymi, reasoning that the dysregulation of cortical TE growth in vivo might also be evident in vitro and would facilitate the isolation of cortical TE lines. As shown in Fig. 1 were labeled with two mAb, 6C3 and NLDC145, that decorate cortical TE in situ (21, 22) , and did not bind mAb that react preferentially with medullary TE in situ (19, 27) or with hematogenously derived thymic non-lymphoid cells (30, 31) . They expressed moderate levels of VCAM-1 and class I MHC products constitutively. Following exposure to 50-100 U/ml of IFN-γ, induction of class II MHC products and ICAM-1, and up-regulation of class I MHC products and VCAM-1 was observed (Fig. 1b) . Constitutive or cytokine-induced expression of B7-1 or B7-2 was not detected. The expression of CD40 by these cells was also examined, based on the pattern of thymic CD40 expression in situ (32, 33) . As shown in Fig (Fig. 1c) . Collectively, these data indicate that the ANV cells exhibit a composite phenotype very similar to cortical TE in situ (NLDC 145 ϩ , 6C3 ϩ , CD40 ϩ , class II MHC ϩ , ICAM-1 ϩ and VCAM-1 ϩ ) when exposed to cytokines thought to be present within the thymic environment in vivo. All of these stromal cell lines expressed the transgene by Northern blot analysis, grew slowly as adherent cells and failed to grow as non-adherent colonies in methylcellulose (data not shown).
ANV stromal cell lines support positive selection in vitro
Cortical epithelium plays a central role in supporting the differentiation of CD4 ϩ CD8 ϩ thymocytes to the more mature CD4 and CD8 SP stage, a process termed positive selection (34, 35) . An RC approach (1) was used to assess the capacity of the ANV cells to support positive selection in vitro. To examine class II MHC-mediated selection events, we utilized H-2 b AND transgenic mice which are deleted when confronted with a H-2 k thymic environment and are positively selected in response to I-A b MHC molecules (15, 16) . CD3-depleted AND thymocytes were cultured on membranes, either alone or with different thymic stromal cell lines previously exposed to IFN-γ in order to up-regulate class II MHC expression. In the absence of stromal cells, CD4 ϩ CD8 ϩ TCR low and CD4 -CD8 -TCR low thymocytes were recovered at the end of 4 day culture period, although with variable cell recovery (Fig. 2a) . Coculture with fibroblasts or a number of adherent cell populations [fibroblasts H-2 d , TEC cells H-2 b ϫ d (17) ] had no effect on the subsequent phenotype of the recovered thymocytes and in some instances dramatically reduced thymocyte viability. In striking contrast, a significant percentage of AND thymocytes from the RC established with ANV 41.2 or ANV100-4 cells (both H-2 k ϫ b ) expressed a CD4 ϩ CD8 -phenotype and thus appeared to have undergone a differentiation program similar to the pattern supported by the intact thymic environment in vivo. In addition to CD4 ϩ CD8 -thymocytes, a subset of the recovered thymocytes displayed a CD4 low CD8 ϩ phenotype. These alterations in CD4 and CD8 expression were accompanied by reduced levels of heat stable antigen (HSA) expression and increased levels of transgenic TCR α chain expression (Fig. 2b) , consistent with the further development of CD4 ϩ CD8 ϩ thymocytes. Elevated levels of CD25 or CD69 were not expressed by thymocytes recovered from the RC (data not shown). The lack of CD25 or CD69 was expected, given that the RC were analyzed at day 4 of culture.
Monitoring the yield of CD4 SP cells in both the input and output thymocyte populations clearly established that the increased percentage of CD4 SP cells represented an absolute increase in number (Fig. 2c) and not simply their selective survival. The thymocytes recovered from RC displayed responsiveness to MCC peptide presented by B10BR splenocytes in secondary cultures, while thymocytes cultured alone did not (Fig. 2c) .
Antibody inhibition studies were performed to explore the role of stromal cell surface molecules on the positive selection process. As shown in Fig. 3 , addition of 6C3 mAb, which binds to ANV cells and cortical TE in situ, and which has no discernible effect on thymocyte development in fetal thymic organ cultures (Farr, unpublished observations), has no effect on the emergence of CD4 SP cells in the RC. In contrast, addition of mAb directed against I-E class II MHC gene products (14.4 .4S) at the initiation of the RC profoundly inhibited the emergence of CD4 low CD8 ϩ and CD4 SP thymocyte populations This effect was not simply due to antibody ligation of stromal cell class II molecules, since blocking mAb directed against I-A b or I-A k gene products (Y3P and 10.3.6 respectively) had little effect (the slight increase in CD4 SP cells in RC treated with 10.3.6 was not reproducible). These results also indicate that I-A b , although capable of supporting positive selection of AND thymocytes in vivo, was not a selecting element in the ANV RC cultures. Combinations of mAb able to block LFA-1-ICAM-1 or VLA-4-VCAM-1 interactions were added to RC to assess their relative contribution to thymocyte-ANV interactions mediating the generation of CD4 SP cells. As shown in Fig. 3(b) , mixtures of mAb directed against LFA-1 and ICAM-1 or VLA-4 and VCAM-1 had little effect on the final frequency of CD4 SP cells in the cultures. Modest inhibition of the accumulation of CD4 SP thymocytes (~25%) was observed only when all four mAb were added to the RC.
Low concentrations of MCC peptide can augment positive selection in RC Most of the experiments described above were done with aliquots of recently thawed ANV cells. ANV cells maintained for long periods of culture often exhibited a reduced ability to support the development of CD4 ϩ SP cells which was accompanied by increased representation of CD4 low CD8 ϩ cells and CD4 low CD8 low cells. Because this alteration in function was not associated with significant alterations of the stromal cell phenotype (data not shown), we explored the possibility that this alteration reflected reduced expression of the ligand mediating selection by including low concentrations of MCC peptide at the initiation of the RC. Results of a representative experiment is shown in Fig. 4 . The inclusion of a relatively low concentration of MCC peptide (0.1 µM) in the RC with the variant ANV cells dramatically increased the representation of CD4 SP thymocytes, and virtually eliminated the CD4 low CD8 ϩ and CD4 ϩ CD8 ϩ cells. This effect of MCC peptide was dependent on the presence on ANV cells, as thymocytes cultured with MCC peptide in the absence of ANV cells failed to differentiate further than the CD4 ϩ CD8 ϩ stage (Fig. 4a) . The increased representation of CD4 SP in these cultures was not due to selective survival of contaminating CD4 SP cells in the input thymocyte population, since their absolute number increased 4-to 80-fold during the coculture period with ANV cells and MCC peptide (Fig. 4b) . Thymocytes recovered from variant ANV RC containing 0.01 µM MCC responded to MCC in secondary culture with mitomycin-treated H-2 k spleen cells, while thymocytes cultured in the presence of MCC peptide but without ANV stromal cells did not (Fig. 4c) .
High concentrations of MCC peptide interfere with positive selection in RC
To determine the effect of increasing the putative selection signal on the pattern of selection occurring in this culture system, RC cultures were established with different concentrations of MCC peptide. The percentage of CD4 SP thymocytes recovered from RC established with variant ANV cells in the presence of 0.1 µM MCC peptide ranged from 45 to 55% (Fig. 5a and data not shown) . Increasing the MCC peptide concentration to 1 µM resulted in a dramatic decrease of CD4 SP cells to 12-18%, which was further reduced to 5-10% in the presence of 10 µM MCC peptide. Although levels of CD4 expression in the presence of 0.01-0.1 µM MCC were not appreciably altered (compare Figs 4a and 5a), 1-10 µM MCC caused a one-half to three-quarter log reduction in the intensity of CD4 labeling. Analysis of transgenic TCR α chain expression by thymocytes recovered from these cultures revealed a concomitant reduction of V α 11 expression in response to increasing peptide concentration. Levels of V α 11 expression at the highest peptide concentration tested, 10 µM, was reduced to levels which were largely overlapping with the levels expressed by the input thymocyte population (Fig.  5a ). The addition of exogenous peptide over a 2-log range of concentration did not affect cellular recoveries in the cultures or result in expression of either CD25 or CD69 at the end of the culture period (data not shown).
Viable thymocytes recovered from RC established with low and high doses of MCC peptide (0.03 and 10 µM) were placed in secondary culture with T cell-depleted B10.BR spleen cells and 1 µM MCC peptide to assess their proliferative response. As shown in Fig. 5(b) , thymocytes recovered from RC established with the variant ANV thymic epithelial cell line and without exogenous MCC peptide could respond ANV stromal cell lines presenting MCC peptide cannot activate peripheral T cells or CD4 SP thymocytes from AND mice Since I-A b cannot effectively present the MCC peptide to AND T cells, the ANV cells are the only potential antigenpresenting cell (APC) in the RC that could mediate antigenspecific activation of the few residual CD4 SP thymocytes. To explore the possibility that the increased numbers of CD4 SP thymocytes recovered from these RC reflected expansion of the few (Ͻ1%) contaminating CD4 SP thymocytes in response to MCC peptide presented by the ANV stromal cells, the conventional antigen-presenting capacity of ANV stromal cells was assessed in several ways. Nylon wool purified AND lymph node T cells were cultured with ANV stromal cells that had been previously incubated with 50 U of IFN-γ to induce class II MHC antigen expression or T cell-depleted spleen cells from B10.BR and C57Bl/6 mice. In all cases, the antigenpresenting population was previously treated with mitomycin C. As shown in Fig. 6(a) , AND lymph node cells responded to MCC peptide when presented by H-2 k (B10.BR) spleen cells, but not by ANV41-2 stromal cells or H-2 b (C57Bl/6) spleen cells. Similar results were observed with unfractionated AND thymocytes (data not shown). Note that the peptide concentration able to support positive selection is less than that optimal for activation of peripheral T cells.
The inability of ANV cells to function as conventional APC was not enhanced by the geometry of the RC. In RC established with purified CD4 SP cells, IFN-γ-treated ANV stromal cells and MCC peptide, the recovery of CD4 ϩ cells from the RC was~5% of the input population in the presence or absence of 1 µM MCC peptide. As shown in Fig. 6(b) , the CD4 SP AND thymocytes recovered from these RC cultures were predominantly resting cells as assessed by their forward light scatter profile and did not exhibit detectable incorporation of BrdU over days 2-4 of culture. In contrast, almost all of the AND thymocytes co-cultured with B10.BR splenocytes and MCC peptide had high forward scatter properties consistent with large cycling cells and had incorporated BrdU over days 2-3 of culture. Furthermore, CD4 SP thymocytes recovered from RC containing cognate peptide did not express the elevated levels of CD44 observed after antigenmediated stimulation in cultures containing splenic APC and MCC (Data not shown). Thus, the accumulation of CD4 SP cells in RC was not due to antigen stimulated expansion of the few residual CD4 SP thymocytes in the double-positive input population. Consistent with these observations, previous studies with another line of MCC-specific, class II-restricted TCR transgenic mice indicated that CD4 SP thymocytes did not proliferate in response to MCC peptide added to fetal thymic organ cultures (35) .
Discussion
With this report, we have demonstrated that cortical TE cell lines can support the development of CD4 class II-restricted TCR transgenic thymocytes in vitro when adapted to the RC system developed by Jenkinson et al. (1) . In contrast to SV40-T immortalized cortical TE cell lines, which cannot form RC and must be incorporated into conventional thymic RC (9), the ANV cells readily form compact RC without additional stromal elements, thus avoiding potential contributions from normal stromal elements in the RC. Criteria for positive selection in this class II MHC-restricted model included increases in the absolute numbers of CD4 SP thymocytes during the 4 day culture period, which indicated their accumulation did not reflect preferential survival of CD4 SP cells and the ability of thymocytes recovered from the RC to respond to MCC when presented by H-2 k splenocytes in secondary culture, demonstrating that the recovered CD4 SP thymocytes were functional. The inability of ANV stromal cells and MCC peptide to activate either peripheral T cells or purified CD4 SP thymocytes in RC also rules out the possibility that the emergence of CD4 SP cells in the RC might be a consequence of antigen-stimulated expansion of the few residual CD4 SP cells within the input thymocyte population. The marked inhibitory activity of anti-class II MHC mAb specific for the stromal cell haplotype indicates that the contribution of ANV cells to the development of CD4 SP cells was not simply to provide a permissive environment able to support selection events initiated in vivo, but required MHC-mediated interactions with ANV stromal cells in vitro. The lack of involvement of I-A b in the positive selection observed in the RC and the usage of I-E as the selecting element was unexpected, given the positive selection observed in H-2 b AND mice. This may reflect qualitative differences in the array of peptide-MHC complexes expressed by cortical TE in vitro versus the intact thymic environment or differences in expression levels of class II MHC or other cell interaction molecules that may affect the avidity of thymocyte-epithelial interations or otherwise alter the character of that interaction. Impaired development of CD4 SP thymocytes in RC containing mAb directed against LFA-1-ICAM-1 and VLA-4-VCAM-1 may similarly reflect contri- butions of these receptor-ligand pairs to the overall avidity of TE-thymocyte interactions (37, 38) . It is likely that the extent of their inhibitory activity would vary according to the TCR affinity for selecting ligand (39) .
Although these studies were done with AND thymocytes derived from positively selecting H-2 b AND mice, similar results have been obtained with thymocytes derived from AND mice bearing a non-selecting MHC background and enriched for double-positive cells by positive selection of CD8 ϩ cells (40) or with MHC class I-restricted CD8 ϩ TCR transgenic thymocytes on a non-selecting background (data not shown), thus making it unlikely that the generation of mature thymocytes upon co-culture with ANV stromal cells was simply permissive for selection events that had been initiated in vivo or that the emergence of mature thymocytes in the RC was due to CD3 ligation during thymocyte fractionation. The behavior of thymocytes from class II-deficient mice bearing the AND TCR transgenes should indicate the extent to which in vivo 'priming' for positive selection occurs in this RC.
Results from the variant ANV cells indicate that class IIrestricted positive selection can be effected by low concentrations of exogenous cognate peptide in vitro. These variant stromal cells preferentially supported the accumulation of a significant population of CD4 low CD8 ϩ AND thymocytes in the absence of cognate peptide. Based on the ability of AND thymocytes to develop along the CD8 lineage in the absence of CD4, Matechak et al. have proposed a quantitative instructional model whereby lineage commitment along the CD4 or CD8 pathway is determined by the net quantity of TCR signals (41) . According to this model, strong TCR-mediated signaling would favor a CD4 lineage commitment and weaker signals would favor development along the CD8 pathway. Thus, the CD4 low CD8 ϩ AND thymocytes which accumulate in the variant ANV RC may reflect intermediate stages in the differentiation of CD8 SP cells (42) due to weaker TCR-mediated signals. Possible changes in the variant cells which could lead to reduced TCR-mediated signaling include alterations in the levels of protein serving as the substrate for endogenous peptides mediating positive selection, alterations in the MHC class II antigen-processing pathway affecting levels of endogenous peptide-MHC complexes able to mediate selection or reduced expression of yet unidentified cell interaction molecules which might lower the avidity of thymocyte-stromal cell interactions.
The ability of low concentrations of MCC peptide to support positive selection in these RC is consistent with in vivo results, where MCC neopeptides expressed intrathymically as a consequence of viral delivery supported positive selection of MCC-reactive T cells (43) . These results are contrasted by the deletion and lack of positive selection which ensues when stimulatory cytochrome c peptide is added to FTOC of class II MHC-restricted, cytochrome c-specific TCR transgenic mice or in other in vitro assays with thymocytes from these mice (36, 44, 45) . The basis for this difference is not presently understood and is currently under investigation. It may reflect the absence of hematogenously derived APC in the RC which bear the appropriate MHC haplotype, and are able to mediate deletion (44) and/or differences in the ability of ANV cells and transfected fibroblasts expressing MHC class II molecules to provide survival/differentiation signals required for positive selection (45) . Accumulation of CD4 -CD8 -and CD4 low CD8 -thymocytes unresponsive to MCC as a consequence of higher concentrations of MCC in the RC may be analogous to the negative selection observed in male HY-TCR-transgenic mice, where the surviving thymocytes expressing HY-specific TCR have reduced levels of CD8 expression and are anergic to male H-2 b stimulator cells (46) . Based on these results and results from other TCR transgenic mice, the appearance of αβ TCR ϩ CD4 -CD8 -thymocytes in negatively selecting TCR transgenic mice has been proposed to reflect the outcome of high-avidity TCR interactions (47) . Additional studies are in progress to further characterize the origin, phenotype and functional properties of the CD4 low CD8 -cells generated in the RC containing high concentrations of MCC peptide.
The ability of cognate peptide at low concentrations to mediate positive selection in this class II-restricted paradigm does not appear to be comparable to the activity of agonist class I-restricted peptides. While low concentrations of such peptides in some fetal thymic organ cultures of thymi from class I-restricted TCR transgenic mice can apparently generate CD8 SP cells (48, 49) , the CD8 SP thymocytes so generated appear to be anergic upon secondary stimulation in vitro (50, 51) .
Finally, these studies indicate that the stimuli that regulate expression of CD40 by murine thymic epithelial cells differs from that described for human thymic epithelial cells, where IFN-γ alone was sufficient to induce significant levels of CD40 (32) . Consistent with other thymic epithelial cell lines (18), we found that class II MHC expression by ANV cells was absolutely dependent on the presence of IFN-γ in vitro. Whether or not IFN-γ represents the physiological stimulus regulating class II expression by TE in vivo is not clear. On the one hand, mature thymocytes can produce high titers of TNF-α and IFN-γ in vitro upon stimulation with phorbol ester and ionophore (52) , and may also produce these cytokines in a physiological setting. However, the observations that IFN-γ -/-mice (53) display normal levels of thymic class II MHC expression (Friend and Farr, unpublished observations) and that class II MHC antigen expression persists in fetal thymic lobes depleted of lymphocytes and other hematogeneously derived elements (54) suggest that alternative stimuli exist in vivo.
The culture system described here represents an in vitro paradigm to examine the several aspects of cortical thymic epithelium and thymocyte development, including the role of exogenous peptides in the positive selection of MHC class II-restricted CD4 ϩ thymocytes (40) , the nature of endogenous peptides that may shape selection processes, the role of thymocyte cell surface molecules that have been implicated in the development of SP thymocytes by antibody ligation studies (55) and possible ligands for these molecules expressed by cortical TE.
